BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17184079)

  • 1. Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.
    Bourne TD; Mandell JW; Matsumoto JA; Jane JA; Lopes MB
    J Neurosurg; 2006 Dec; 105(6 Suppl):465-9. PubMed ID: 17184079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
    Rodriguez FJ; Perry A; Rosenblum MK; Krawitz S; Cohen KJ; Lin D; Mosier S; Lin MT; Eberhart CG; Burger PC
    Acta Neuropathol; 2012 Nov; 124(5):627-41. PubMed ID: 22941225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.
    Schniederjan MJ; Alghamdi S; Castellano-Sanchez A; Mazewski C; Brahma B; Brat DJ; Brathwaite CD; Janss AJ
    Am J Surg Pathol; 2013 May; 37(5):763-71. PubMed ID: 23588371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child.
    Rossi S; Rodriguez FJ; Mota RA; Dei Tos AP; Di Paola F; Bendini M; Agostini S; Longatti P; Jenkins RB; Giannini C
    Acta Neuropathol; 2009 Oct; 118(4):575-7. PubMed ID: 19562354
    [No Abstract]   [Full Text] [Related]  

  • 5. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
    Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
    Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.
    Griffin CA; Burger P; Morsberger L; Yonescu R; Swierczynski S; Weingart JD; Murphy KM
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):988-94. PubMed ID: 17021403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary diffuse leptomeningeal oligodendrogliomatosis with an isolated 1p deletion.
    Gatzert S; Durgam A; Raghuram K; Agarwal A
    Br J Neurosurg; 2023 Aug; 37(4):869-874. PubMed ID: 31752539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
    Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
    J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.
    Nambirajan A; Suri V; Kedia S; Goyal K; Malgulwar PB; Khanna G; Panda PK; Gulati S; Garg A; Sharma MC
    Brain Tumor Pathol; 2018 Jul; 35(3):186-191. PubMed ID: 30030640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis.
    Guppy KH; Akins PT; Moes GS; Prados MD
    J Neurosurg Spine; 2009 Jun; 10(6):557-63. PubMed ID: 19558288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji M; Fortin D; Tsanaclis AM; Drouin R
    Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
    Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
    Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
    Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K
    Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal dissemination of a pediatric neoplasm with 1p19q deletion showing mixed immunohistochemical features of an oligodendroglioma and neurocytoma.
    Rhiew RB; Manjila S; Lozen A; Guthikonda M; Sood S; Kupsky WJ
    Acta Neurochir (Wien); 2010 Aug; 152(8):1425-9. PubMed ID: 20446099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
    Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
    Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse leptomeningeal glioneuronal tumor without KIAA1549-BRAF fusion and 1p detection: a case report and review of literature.
    Cheng W; He L; Zhu J; Fan X
    Childs Nerv Syst; 2022 Feb; 38(2):279-285. PubMed ID: 34977973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A.
    Stödberg T; Deniz Y; Esteitie N; Jacobsson B; Mousavi-Jazi M; Dahl H; Zweygberg Wirgart B; Grillner L; Linde A
    Neuropediatrics; 2002 Oct; 33(5):266-70. PubMed ID: 12536370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.
    Kros JM; Gorlia T; Kouwenhoven MC; Zheng PP; Collins VP; Figarella-Branger D; Giangaspero F; Giannini C; Mokhtari K; Mørk SJ; Paetau A; Reifenberger G; van den Bent MJ
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):545-51. PubMed ID: 17549014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.